---
figid: PMC10456809__metabolites-13-00960-g006
pmcid: PMC10456809
image_filename: PMC10456809__metabolites-13-00960-g006.jpg
figure_link: /pmc/articles/PMC10456809/figure/F6/
number: Figure 6
figure_title: Specnuezhenide (SPN) treatment improved gut microbiota disbalance.
caption: Specnuezhenide (SPN) treatment improved gut microbiota disbalance. (A) Principal
  correlation coefficient analysis (PCoA) analysis of gut microbiota at operational
  taxonomic units (OTUSA) level based on Bray−Curtis. (B) Shared and unique OTUs among
  the different groups. (C) The predicted functional metabolic pathways. (D) The relative
  abundance of bile salt hydrolase (BSH) related phylum (n = 5). Data are expressed
  as mean ± SD. * p < 0.05 compared with the MOD group
article_title: Specnuezhenide Ameliorates Age-Related Hepatic Lipid Accumulation via
  Modulating Bile Acid Homeostasis and Gut Microbiota in D-Galactose-Induced Mice
citation: Xuehui Deng, et al. Metabolites. 2023 Aug;13(8).
year: '2023'
pub_date: 2023-8-
epub_date: 2023-8-18
doi: 10.3390/metabo13080960
journal_title: Metabolites
journa_nlm_ta: Metabolites
publisher_name: MDPI
keywords:
- Specnuezhenide
- lipid accumulation
- bile acids
- gut microbiota
---
